ArticleNPJ vaccines2022

Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities.

Nathalie Charland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.